CompletedNot applicableNCT06839378
Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei
Studying Pseudomyxoma peritonei
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Principal Investigator
- Yan Li, PhDBeijing Tsinghua Changgeng Hospital
- Intervention
- intravenously inject with 5-FU (400 mg/m2)(procedure)
- Enrollment
- 36 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2025 – 2025
Study locations (1)
- Beijing Tsinghua Changgung Hospital, Beijing, China
Collaborators
Tsinghua University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06839378 on ClinicalTrials.govOther trials for Pseudomyxoma peritonei
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07328737One vs Three HIPEC Cycles After CRS for Pseudomyxoma PeritoneiBeijing Tsinghua Chang Gung Hospital
- RECRUITINGEARLY PHASE1NCT07341360Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma PeritoneiOslo University Hospital
- RECRUITINGNCT02073500Peritoneal Surface Malignancies - Characterization, Models and Treatment StrategiesOslo University Hospital